دورية أكاديمية
Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area.
العنوان: | Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area. |
---|---|
المؤلفون: | Dawudi Y; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France. yachar.dawudi@aphp.fr.; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France. yachar.dawudi@aphp.fr., Azoyan L; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France.; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France., Broucker TDE; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France., Gendre T; Neurology Department, Hôpital Henri-Mondor, 1 Rue Gustave Eiffel, 94000, Créteil, France., Miloudi A; Neurology Department, Centre Hospitalier Intercommunal Robert Ballanger, Bd Robert Ballanger, 93600, Aulnay-Sous-Bois, France., Echaniz-Laguna A; Neurology Department, Hôpital Bicêtre, 78 Rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France., Mazoyer J; Neurology Department, Hôpital Avicenne, 125 Route de Stalingrad, 93009, Bobigny, France., Zanin A; Clinical Physiology Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France., Kubis N; Clinical Physiology Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France., Dubessy AL; Neurology Department, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France., Gorza L; Neurology Department, Hôpital Foch, 40 Rue Worth, 92150, Suresnes, France., Ben Nasr H; Neurology Department, Centre Hospitalier Sud Francilien, 40 Avenue Serge Dassault, 91100, Corbeil-Essonnes, France., Caré W; Department of Internal Medicine, Bégin Military Teaching Hospital, Saint-Mandé, France.; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France., d'Izarny-Gargas T; Paris Cardiovascular Research Center, INSERM U970, Paris, France., Formoso A; Neurology Department, Hôpital de La Pitié Salpêtrière, 47-83 Bd de L'Hôpital, 75013, Paris, France., Vilcu AM; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France., Bonnan M; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France. |
المصدر: | Journal of neurology [J Neurol] 2024 Jun; Vol. 271 (6), pp. 3340-3346. Date of Electronic Publication: 2024 Mar 13. |
نوع المنشور: | Journal Article; Multicenter Study |
اللغة: | English |
بيانات الدورية: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Berlin ; New York, Springer-Verlag |
مواضيع طبية MeSH: | Nitrous Oxide*/adverse effects , Substance-Related Disorders*/epidemiology, Humans ; Male ; Female ; Adult ; Retrospective Studies ; Paris/epidemiology ; Young Adult ; Middle Aged ; Incidence ; Nervous System Diseases/epidemiology ; Nervous System Diseases/chemically induced ; Peripheral Nervous System Diseases/epidemiology ; Peripheral Nervous System Diseases/chemically induced ; Spinal Cord Diseases/epidemiology ; Spinal Cord Diseases/chemically induced ; Aged ; Adolescent ; Recreational Drug Use/statistics & numerical data |
مستخلص: | Background: Recreational nitrous oxide (N Methods: We performed a retrospective multicentric cohort study of all adult patients with severe NI-NDs in the neurology and general internal medicine departments of the Greater Paris area from 2018 to 2021. The incidence was compared with that of non-NI-myelitis and Guillain-Barré syndrome (GBS) using a sample of 91,000 hospitalized patients sourced from health insurance data. Results: Among 181 patients, 25% had myelopathy, 37% had peripheral neuropathy and 38% had mixed disease. Most were aged between 20 and 25 years, lived in socially disadvantaged urban areas, and exhibited high rates of unemployment (37%). The incidence of NI-NDs increased during 2020 and reached a peak mid-2021. The 2021 incidence in 20-25-year-olds was 6.15 [4.72; 8.24] per 100,000 persons for NI-myelopathy and 7.48 [5.59; 9.37] for NI-peripheral neuropathy. This was significantly higher than for non-NI-myelitis (0.35 [0.02; 2.00]) and GBS (2.47 [0.64; 4.30]). The incidence of NI-NDs was two to three times higher in the most socially disadvantaged areas. Conclusion: The recent increase in recreational N (© 2024. The Author(s).) |
References: | Sumnall H (2022) Recreational use of nitrous oxide. BMJ 378:o2297. https://doi.org/10.1136/bmj.o2297. (PMID: 10.1136/bmj.o229736167405) Randhawa G, Bodenham A (2016) The increasing recreational use of nitrous oxide: history revisited. Br J Anaesth 116(3):321–324. https://doi.org/10.1093/bja/aev297. (PMID: 10.1093/bja/aev29726323292) Xiang Y, Li L, Ma X et al (2021) Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment. Neurotox Res 39(3):975–985. https://doi.org/10.1007/s12640-021-00352-y. (PMID: 10.1007/s12640-021-00352-y33770366) Sanders RD, Weimann J, Maze M, Warner DS, Warner MA (2008) Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 109(4):707–722. https://doi.org/10.1097/ALN.0b013e3181870a17. (PMID: 10.1097/ALN.0b013e3181870a1718813051) Layzer RB, Fishman RA, Schafer JA (1978) Neuropathy following abuse of nitrous oxide. Neurology 28(5):504–504. https://doi.org/10.1212/WNL.28.5.504. (PMID: 10.1212/WNL.28.5.504205816) Zheng D, Ba F, Bi G, Guo Y, Gao Y, Li W (2020) The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol 267(2):422–429. https://doi.org/10.1007/s00415-019-09600-w. (PMID: 10.1007/s00415-019-09600-w31655888) Mair D, Paris A, Zaloum SA et al (2023) Nitrous oxide-induced myeloneuropathy: a case series. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2023-331131 . (Published online May 30, 2023). (PMID: 10.1136/jnnp-2023-33113137253616) Guerlais M, Aquizerate A, Lionnet A et al (2023) Nitrous oxide: a unique official French addictovigilance national survey. Front Public Health 11:1167746. https://doi.org/10.3389/fpubh.2023.1167746. (PMID: 10.3389/fpubh.2023.11677463720687110189051) Scailteux LM, Droitcourt C, Balusson F et al (2019) French administrative health care database (SNDS): the value of its enrichment. Therapies 74(2):215–223. https://doi.org/10.1016/j.therap.2018.09.072. (PMID: 10.1016/j.therap.2018.09.072) Oussalah A, Julien M, Levy J et al (2019) Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. J Clin Med 8(4):551. https://doi.org/10.3390/jcm8040551. (PMID: 10.3390/jcm8040551310186136518054) Accueil | Direction de la recherche, des études, de l’évaluation et des statistiques. Accessed Nov 1, 2023. https://drees.solidarites-sante.gouv.fr/. Accueil - Insee - Institut national de la statistique et des études économiques. Accessed Nov 1, 2023. https://www.insee.fr/fr/accueil. Rosenberg H, Orkin FK, Springstead J (1979) Abuse of nitrous oxide. Anesth Analg 58(2):104–106. (PMID: 10.1213/00000539-197903000-00009571232) Kaar SJ, Ferris J, Waldron J, Devaney M, Ramsey J, Winstock AR (2016) Up: the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. J Psychopharmacol 30(4):395–401. https://doi.org/10.1177/0269881116632375. (PMID: 10.1177/026988111663237526912510) van Amsterdam J, Nabben T, van den Brink W (2015) Recreational nitrous oxide use: prevalence and risks. Regul Toxicol Pharmacol 73(3):790–796. https://doi.org/10.1016/j.yrtph.2015.10.017. (PMID: 10.1016/j.yrtph.2015.10.01726496821) Thevenin M (2023) Épidémiologie de la consommation récréative de protoxyde d’azote chez les étudiants en médecine d’Ile-de-France. Doctoral thesis. Université Paris Cité. Winstock AR, Ferris JA (2020) Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users. J Psychopharmacol 34(2):229–236. https://doi.org/10.1177/0269881119882532. (PMID: 10.1177/026988111988253231679459) Barnhill JW (2013) DSM-5® clinical cases. American Psychiatric Pub. (PMID: 10.1176/appi.books.9781585624836) Wu G, Wang S, Wang T et al (2022) Neurological and psychological characteristics of young nitrous oxide abusers and its underlying causes during the COVID-19 lockdown. Front Public Health 10:854977. https://doi.org/10.3389/fpubh.2022.854977. (PMID: 10.3389/fpubh.2022.854977357196239201030) Nabben T, Weijs J, van Amsterdam J (2021) Problematic use of nitrous oxide by young moroccan-dutch adults. Int J Environ Res Public Health 18(11):5574. https://doi.org/10.3390/ijerph18115574. (PMID: 10.3390/ijerph18115574340710878197142) Lapeyre-Mestre M, Boucher A, Daveluy A et al (2020) Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Therapie 75(4):343–354. https://doi.org/10.1016/j.therap.2020.06.006. (PMID: 10.1016/j.therap.2020.06.006326607767309935) Bethmont A, Harper CE, Chan BS, Dawson AH, McAnulty J (2019) Increasing illicit use of nitrous oxide in presentations to NSW emergency departments. Med J Aust 211(9):429–429. https://doi.org/10.5694/mja2.50377 . (e1). (PMID: 10.5694/mja2.5037731625166) European Monitoring Centre for Drugs and Drug Addiction. Recreational nitrous oxide use in Europe: situation, risks, responses. Accessed Nov 4, 2023. https://www.emcdda.europa.eu/publications/topic-overviews/recreational-nitrous-oxide-use-europe-situation-risks-responses_en. Winstock A, Munksgaard R, Davies E, Ferris J, ZhuParris A, Barratt M (2022) Drug trend report: time, music, clubbing, age, and diet. Global Drug Survey. |
فهرسة مساهمة: | Keywords: Epidemiology; Myelopathy; Nitrous oxyde abuse; Peripheral neuropathy |
المشرفين على المادة: | K50XQU1029 (Nitrous Oxide) |
تواريخ الأحداث: | Date Created: 20240313 Date Completed: 20240529 Latest Revision: 20240718 |
رمز التحديث: | 20240719 |
مُعرف محوري في PubMed: | PMC11136741 |
DOI: | 10.1007/s00415-024-12264-w |
PMID: | 38478030 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1432-1459 |
---|---|
DOI: | 10.1007/s00415-024-12264-w |